We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Research · March 16, 2021

Outcomes in Patients With Advanced Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors

Urologic Oncology: Seminars & Original Investigations

 

Additional Info

Urologic Oncology: Seminars & Original Investigations
Characterization of Outcomes in Patients With Advanced Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors
Urol. Oncol 2021 Jan 22;[EPub Ahead of Print], VT Ma, CT Su, M Hu, JMG Taylor, S Daignault-Newton, O Kellezi, MN Dahl, MA Shah, S Erickson, J Lora, R Hamasha, A Ali, S Yancey, L Kiros, HM Balicki, DC Winfield, MD Green, AS Alva

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading